Zyla Life Sciences Marketable Securities (Current)
Zyla Life Sciences had Marketable Securities (Current) of $5.00 million as of 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2019-03-29
- 2018-12-31: Marketable Securities, Current $5.00M.
- 2018-09-30: Marketable Securities, Current $16.00M.
- 2018-06-30: Marketable Securities, Current $32.20M.
- 2018-03-31: Marketable Securities, Current $40.80M.
| Period end | Marketable Securities, Current |
|---|---|
| 2018-12-31 | $5.00M 10-K · filed 2019-03-29 |
| 2018-09-30 | $16.00M 10-Q · filed 2018-11-19 |
| 2018-06-30 | $32.20M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $40.80M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $60.00M 10-K · filed 2018-03-16 |
| 2017-09-30 | $64.30M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $43.90M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $56.20M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $33.20M 10-K · filed 2017-03-13 |
| 2016-09-30 | $41.60M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $54.50M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $65.00M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $75.90M 10-K · filed 2016-03-11 |
| 2015-09-30 | $63.70M 10-Q · filed 2015-11-06 |